Use the Back button in your browser to see the other results of your search or to select another record.

Detailed Search Results

Clinical trial of a formal group fatigue program in multiple sclerosis
Hugos CL, Copperman LF, Fuller BE, Yadav V, Lovera J, Bourdette DN
Multiple Sclerosis 2010 Jun;16(6):724-732
clinical trial
5/10 [Eligibility criteria: Yes; Random allocation: Yes; Concealed allocation: Yes; Baseline comparability: Yes; Blind subjects: No; Blind therapists: No; Blind assessors: No; Adequate follow-up: No; Intention-to-treat analysis: No; Between-group comparisons: Yes; Point estimates and variability: Yes. Note: Eligibility criteria item does not contribute to total score] *This score has been confirmed*

Fatigue: take control is a novel program to teach fatigue management to people with multiple sclerosis (MS) following recommendations in the fatigue and multiple sclerosis guideline. Fatigue: take control includes six 2-hour group sessions with DVD viewing, discussion and homework and accompanying participant and leader workbooks. While many people have participated in fatigue: take control programs, its efficacy has not been determined. The objective of this study was to determine whether participation in fatigue: take control reduces fatigue and increases self-efficacy in people with MS. Thirty participants were randomly assigned to a group who immediately participated in the program (FTC) or a wait-list group (WL). The primary outcome was the Modified Fatigue Impact Scale (MFIS) and secondary outcomes were the Multiple Sclerosis Self-Efficacy Scale (MSSE) and the Fatigue Severity Scale (FSS). The MFIS was administered on 10 occasions. Other measures were administered on four occasions. A mixed model tested the effects using all observations. Compared with the WL, the FTC group had significantly more improvement on the MFIS (F[1,269] = 7.079, p = 0.008) and the MSSE (F[1,111] = 5.636, p = 0.019). No significant effect was found for the FSS. Across all visits, fatigue was significantly lower and self-efficacy was significantly higher for the FTC group compared with the WL group. This pilot study demonstrated significant effects in fatigue and self-efficacy among subjects taking the fatigue: take control program, suggesting that this comprehensive program based on the fatigue and multiple sclerosis guideline may be beneficial in MS.

Full text (sometimes free) may be available at these link(s):      help